Pathway Intermediates Limited is delighted to report that it has appointed Dr. John Springate as its first Chairman. When Pathway Intermediates Limited was launched in 2001, the two founding Directors did not expect that it would grow to be the global brand that it now is, and so there was no thought of appointing a Chairman at that time. Following a restructure of the Pathway business in 2021 the Board decided to appoint a Chairman who could help steer the company as it moved to a new chapter of development.
Dr. Springate joins Pathway after extensive global experience in the animal health and nutrition sector, having worked for well-respected companies in Europe, Asia and America. Edward Youngman, CEO of Pathway Intermediates Limited said ‘I am delighted that we have been able to secure a Chairman of John’s calibre and look forward to continue to work closely with him to further grow the business. Pathway Intermediates Limited has seen sales growth in excess of 50% in the first half of 2022 and John has played an important role in helping to shape our strategy and deliver against it’. Dr. Springate commented that ‘the Pathway ethos and the focus on the Science of Feeding Tomorrow make it well placed to use its science to deliver effective and sustainable feed additives for a growing global population.’